Location History:
- Whitmore Lake, MI (US) (1995)
- Howell, MI (US) (2004)
Company Filing History:
Years Active: 1995-2004
Title: **Roy Douville Schwarz: Innovator in Pharmaceutical Chemistry**
Introduction
Roy Douville Schwarz, an accomplished inventor based in Howell, MI, has made significant contributions to the field of pharmaceutical chemistry. With a total of two patents to his name, his work primarily focuses on innovative treatments for neurological conditions, particularly Parkinson's disease.
Latest Patents
Among his latest innovations is a patent for Benzoxazines, which are crucial in the treatment of Parkinson's disease. These compounds, described as Benzoxazines of Formula (I), offer potential therapeutic benefits for patients suffering from movement disorders. The patent outlines various molecular configurations, including alkyl and alkenyl groups, that enhance their efficacy as treatments.
Additionally, Schwarz has contributed to the development of substituted tetrahydropyridine and piperidine carboxylic acids and their derivatives. This patent details methods for preparing these compounds and their pharmaceutical compositions. The muscarinic antagonists derived from these compounds are valuable in managing several conditions, such as bradycardia, bronchoconstriction, urinary incontinence, and even Alzheimer's disease, showcasing a wide range of therapeutic applications.
Career Highlights
Roy Douville Schwarz is currently affiliated with the Warner-Lambert Company, where he applies his innovative spirit and scientific expertise to advance pharmaceutical research and product development. His work not only highlights his individual contributions but also reflects the broader commitment of his company to enhancing healthcare through cutting-edge innovation.
Collaborations
Schwarz collaborates with notable colleagues, including Corinne E Augelli-Szafran and Juan C Jaen. These partnerships foster a creative and stimulating environment conducive to groundbreaking research, allowing for the exploration of new therapeutic avenues and the development of novel pharmaceutical solutions.
Conclusion
In summary, Roy Douville Schwarz stands out as an influential inventor in pharmaceutical chemistry, whose innovative work has the potential to significantly impact the treatment of Parkinson's disease and other neurological conditions. His contributions illustrate the vital role of inventors in advancing medical science and improving patient outcomes through innovative therapies.